Buradasınız

Seminom ve Budd-Chiary Sendromu Birlikteliği: Olgu Sunumu

Coexistance of Seminoma and Budd-Chiary Syndrome: Case Report

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Thrombosisisacommon complication andoneof theleadingcauses of death related to cancer. Thrombosis and Budd-Chiary syndrome occur rarely in patients with testicular tumors. In a patient who was operated related to seminoma, abdominal metastatic masses andthrombsisin hepaticvein and vena cava inferior were detected on both abdominal doppler ultrasonograhy andcomputerizedtomography. When liverfunction abnormalitieswere also seen, the patientwasdiagnosedasBudd- Chiary syndrome and startedwith heparin therapy after exclusion of other causes of thrombosis.
Abstract (Original Language): 
Kanserli hastalarda tromboz sık rastlanan bir komplikasyon olup kansere bağlıölümlerinbaştagelennedenleriarasında yeralmaktadır. Testistümörlü hastalarda seyrek de olsa tromboz ve buna bağlı Budd-Chiary sendromu gelişebilmektedir. Seminomnedeniiledaha önceopereedilmişolan bir hastada abdominal metastatik kitleler ilebirlikteabdominal dopplerUSGve Bilgisayarlıtomografidehepatikvenvevena kava inferiorda yaygıntrombüslersaptandı. Karaciğerfonksiyonbozukluğunun tespit edilmesiüzerinediğer tromboz nedenleridışlandıktan sonraBudd-Chiarysendromu tanısıileheparin tedavisi başlandı.
53
56

REFERENCES

References: 

1. Wun T, White RH. Venous thromboembolism in
patients with cancer, epidemiology and risk factors.
2009;27 Suppl 1:63-74.
2. Kvolik S. An overview of coagulation disorders in
cancerpatient, surgical oncology.2009;18.
3. Obitsu Y. Shigematsu H. Gantokagaku Ryoho.
Deep vein thrombosis inpatients with cancer. Review
Japonase 2009;36:535-539.
4. Mano MS, Guimarães JL, Sutmöller SF, et al. Extensive
deep vein thrombosis as a complication of testicular
cancer treated with the BEP protocol (bleomycin,
etoposide and cisplatin): case report. Sao Paulo Med
J. 2006 7;124:343-345.
5. Behrendt CE, Ruiz RB. Venous thromboembolism
among patients with advanced lung cancer randomised
to prinomastat or plasebo, plus chemotherapy.
Thromb Haemost 2003;90:734-741.
6. Fuminoro Sato, Hajime Yamazaki, Ken Ataka, et al.
Malignant peritoneal mesothelioma associated with deep
vein thrombosis following radiotherapy for seminoma of
the testis. Internal Medicine 2000, 39:920-924.
7.Geerts WH, Pineo GF, Heit JA et al. Prevention
of venous thromboembolism: the Seventh ACCPon antithrombotic and thrombolytic therapy. Chest
2004;126:338-400.
8. Bauer KA. Venous thromboembolism in malignancy
(editorial) Journal of Clinical Oncology. 2000;18:3065-
3072.
9. Moucari R, Rautou PE, Cazals-Hatem D. et al
Hepatocelluler carcinoma in Budd Chiari syndrome:
characteristics and risk factors. 2008;57:828-863.
10. Shih KL, Yen HH, Su WW, Soon MS, Hsia CH, Lin
YM. Fulminant Budd Chiari syndrome caused by renal
cell carcinoma, with hepatic vein invasion: report of a
case. Eur J Gastroentero Hepatol. 2009;21:222-226.
11. Law JK, Davis J, Buckley A, Salh B. Intrahepatic
cholangiocarcinoma preseting as the Budd-Chiary
syndrome: a case reportand literature review, Can J
Gastroenterol. 2005;19:723-728.
12. Hoekstra J, Janssen HL. Diagnosis, treatment
and prognosis of Budd Chiari Syndrome . Netherlands
Journal of Medicine 2008; 66:334-339.

Thank you for copying data from http://www.arastirmax.com